Biomedical Investments

Portfolio · 2

Gamida Cell

Cellular and Immune Therapies

1 round $16.0M committed Latest: 2006-09

XTL Biopharmaceuticals

Treatments for Autoimmune Diseases

1 round $1.3M committed Latest: 2004-11

Investment activity

1 portfolio exit on record.

Q&A

What is Biomedical Investments' primary sector focus?

Biomedical Investments primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.

Can you name some of Biomedical Investments' notable portfolio companies?

Biomedical Investments' portfolio includes Gamida Cell, which specializes in Cellular.

Has Biomedical Investments had any exits?

Yes, Biomedical Investments had an exit in October 2018 with Gamida Cell, which went public on NASDAQ with a valuation of $210M.

What is the typical investment range for Biomedical Investments?

Biomedical Investments typically invests between $1.34M and $16M.

What funding stages does Biomedical Investments typically participate in?

Biomedical Investments has participated in Seed and D Round funding stages.

When was Biomedical Investments founded?

Biomedical Investments was created on startupim in May 2019.